Expression and possible role of interleukin-10 receptors in patients with adenomyosis
article
OA: closed
CC0
⤵ 16 in-corpus citations
AI-generated summary
This study investigated the expression of interleukin-10 receptors in patients with adenomyosis to understand their potential role in the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo investigate the expression and potential roles of interleukin-10 receptor 1 (IL-10R1) and interleukin-10 receptor 2 (IL-10R2) in adenomyosis.Study designThis prospective study examined 33 women with histologically proven adenomyosis and 21 women without adenomyosis who had undergone hysterectomy for non-endometrial pathology. Comparative immunohistochemistry was used to evaluate the expression and localization of IL-10R1 and IL-10R2. Tissue sections were immunostained with goat anti-human interleukin-10 receptor alpha and rabbit anti-human interleukin-10 receptor beta antibodies. The presence and localization of IL-10R1 and IL-10R2 were evaluated microscopically throughout the menstrual cycle in eutopic and ectopic endometrial tissues of women with adenomyosis, and the results were compared with those for normal endometrium.ResultsIL-10R1 and IL-10R2 were mainly expressed by epithelial cells in both women with adenomyosis and controls. Epithelial expression of IL-10R1 and IL-10R2 was higher in adenomyotic samples than in eutopic endometrium of women with adenomyosis or normal endometrium. Moreover, epithelial expression of IL-10R1 was higher in eutopic endometrium of women with adenomyosis than in normal endometrium. Epithelial expression of IL-10R1 showed cyclic variation in eutopic endometrium of women with adenomyosis and normal endometrium, with elevated expression in secretory-phase tissues compared with proliferative-phase tissues.ConclusionsIntrinsic abnormalities concerning IL-10 and IL-10 receptors may be present in eutopic and ectopic endometria of women with adenomyosis. These findings suggest that IL-10 receptors may be involved in the immunotolerant and/or anti-inflammatory process of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Cytokine Network of Eutopic and Ectopic Endometrium in Women with Adenomyosis via openalex
- Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis via openalex
- Evidence for estrogen synthesis in adenomyotic tissues via openalex
- Inflammation in Reproductive Disorders via openalex
- Pathophysiology of adenomyosis via openalex
- Risk factors for adenomyosis via openalex
- W1993472421 via openalex
- W2013283905 via openalex
- W2017896938 via openalex
- W2019042264 via openalex
- W2023845407 via openalex
- W2028763115 via openalex
- W2029675712 via openalex
- W2058218898 via openalex
- W2083715429 via openalex
- W2097390476 via openalex
- W2097904070 via openalex
- W2102151740 via openalex
- W2114177134 via openalex
- W2131686775 via openalex
- W2134999383 via openalex
- W2154143583 via openalex
- W2204640292 via openalex
- W2285724160 via openalex
- W11141567 via openalex
- W6610406119 via openalex
- W287314825 via openalex
- W1511967417 via openalex
- W1944006756 via openalex
- W1987073290 via openalex
- W1993160730 via openalex
Cited by (16)
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review 2023
- IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression 2022
- Mifepristone Inhibited the Expression of B7-H2, B7-H3, B7-H4 and PD-L2 in Adenomyosis 2021
- The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea 2020
- Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis 2020
- Comparing Interleukin 10 (IL-10) Level in Women with Adenomyosis and without Adenomyosis 2019
- Current facts constituting an understandingof the nature of adenomyosis 2018
- Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis 2017
- Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment 2017
- Serum level concentrations of pro-inflammatory cytokines in patients with adenomyosis 2017
- Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients 2016
- The Endometrium in Adenomyosis 2015
- Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. 2015
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. 2014
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- The Endometrium in Adenomyosis 2012
Source provenance
- europepmc
- last seen: 2026-09-02T07:05:44.937405+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:23.388809+00:00
- unpaywall
- last seen: 2026-09-02T07:26:43.000666+00:00
License: CC0
· commercial use OK